跳至主要内容
临床试验/NCT02876484
NCT02876484已完成4 期

Effects of Chenodeoxycholic Acid and Colesevelam on GLP-1 Secretion, During a Meal, After Roux-en-Y Gastric Bypass

Hvidovre University Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
1
主要终点
GLP-1 secretion (evaluated by iAUC)

研究概览

简要总结

The purpose of this study is to examine the effects of bile acid and bile acids sequestrants on GLP-1 Secretion, during a meal, in patients after Roux-en-Y gastric bypass.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Uncomplicated RYGB performed minimum 3 months prior to the study.
  • Fasting plasma glucose < 7,0 mM, HbA1c < 48 mmol/mol 3 months after RYGB

排除标准

  • Fasting plasma glucose > 7,0 mM, HbA1c > 48 mmol/mol 3 months after RYGB.
  • Dysregulated thyroid diseases, use of antithyroid treatment.
  • Late diabetic complications as retinopathy, renal insufficiency, neuropathy or previous pancreatitis.
  • Complications to RYGB. Documented reactive hypoglycaemia, severe dumping (vomiting, diarrhea, severe abdominal pain after food intake).
  • Cholecystectomy

研究组 & 干预措施

Placebo

Experimental

Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM.

25 ml water

干预措施: Water (Other)

Chenodeoxycholic Acid

Experimental

Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Chenodeoxycholic acid (1250 mg) mixed in 25 ml yoghurt

干预措施: Chenodeoxycholic Acid (Drug)

Colesevelam

Experimental

Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Colesevelam (3,75 g) dissolved in 25 ml water and mixed in 25 ml yoghurt.

干预措施: Colesevelam (Drug)

Colesevelam x 2

Experimental

plus (on another study day) 3,75 g colesevelam administered the evening before the experiment. Morning meal: brown bread, margarine, cheese, yoghurt, oatmeal, raisins, almonds, water, PCM. Colesevelam (3,75 g) dissolved in 25 ml water and mixed in 25 ml yoghurt.

干预措施: Colesevelam (Drug)

结局指标

主要结局

GLP-1 secretion (evaluated by iAUC)

时间窗: -10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes after mixed meal

次要结局

  • Insulin secretion(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • PYY secretion(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Bile acids/FGF19 concentrations(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Glucose levels(-10, 0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • PCM levels(Baseline, 0, 5, 10, 15, 20, 30, 45, 60, 90, 120, 180, 240 minutes)
  • CCK secretion(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Total bile acid secretion(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Appetite measurements (VAS-score)(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • C-peptide secretion(Baseline, 0, 5, 10, 20, 30, 45, 60, 90, 120, 180, 240 minutes)
  • Glucagon secretion(Baseline, 0, 10, 20, 30, 45, 60, 90, 120, 180, 240 minutes)
  • GIP secretion(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)
  • Ghrelin(0, 10, 20, 30, 45, 60, 90, 120, 180 and 240 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Saur Svane

MD

Hvidovre University Hospital

研究点 (1)

Loading locations...

相似试验